NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.28 million. The enterprise value is -$2.58 million.
| Market Cap | 1.28M |
| Enterprise Value | -2.58M |
Important Dates
The next estimated earnings date is Wednesday, December 2, 2026.
| Earnings Date | Dec 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 1.12 million shares outstanding.
| Current Share Class | 1.12M |
| Shares Outstanding | 1.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.29% |
| Owned by Institutions (%) | 0.08% |
| Float | 1.07M |
Valuation Ratios
The trailing PE ratio is 1.16 and the forward PE ratio is 0.00.
| PE Ratio | 1.16 |
| Forward PE | 0.00 |
| PS Ratio | 0.28 |
| Forward PS | n/a |
| PB Ratio | 0.05 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.06 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.79 |
Financial Efficiency
Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is -50.49%.
| Return on Equity (ROE) | 5.51% |
| Return on Assets (ROA) | -26.91% |
| Return on Invested Capital (ROIC) | -50.49% |
| Return on Capital Employed (ROCE) | -42.55% |
| Weighted Average Cost of Capital (WACC) | 23.49% |
| Revenue Per Employee | $53,238 |
| Profits Per Employee | $12,864 |
| Employee Count | 87 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 15.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is 0.06, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 21.58 |
| 200-Day Moving Average | 424.73 |
| Relative Strength Index (RSI) | 22.64 |
| Average Volume (20 Days) | 4,017,229 |
Short Selling Information
The latest short interest is 70,041, so 6.28% of the outstanding shares have been sold short.
| Short Interest | 70,041 |
| Short Previous Month | 16,516 |
| Short % of Shares Out | 6.28% |
| Short % of Float | 6.56% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.63 million and earned $1.12 million in profits.
| Revenue | 4.63M |
| Gross Profit | 1.11M |
| Operating Income | -11.03M |
| Pretax Income | 951,299 |
| Net Income | 1.12M |
| EBITDA | -10.76M |
| EBIT | -11.03M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $5.51 million in cash and $1.65 million in debt, with a net cash position of $3.86 million or $3.46 per share.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | 1.65M |
| Net Cash | 3.86M |
| Net Cash Per Share | $3.46 |
| Equity (Book Value) | 25.71M |
| Book Value Per Share | n/a |
| Working Capital | 618,325 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -135,025 |
| Depreciation & Amortization | 272,413 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.06M |
| FCF Per Share | -$9.91 |
Margins
Gross margin is 23.89%, with operating and profit margins of -238.22% and 24.16%.
| Gross Margin | 23.89% |
| Operating Margin | -238.22% |
| Pretax Margin | 20.54% |
| Profit Margin | 24.16% |
| EBITDA Margin | -232.34% |
| EBIT Margin | -238.22% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 86.48% |
| FCF Yield | -854.69% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 285.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 23, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Oct 23, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
NewGenIvf Group has an Altman Z-Score of -0.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.71 |
| Piotroski F-Score | 1 |